Head and neck cancer

2018 ◽  
Vol 11 (6) ◽  
pp. 342-346 ◽  
Author(s):  
Tobias Moorhouse ◽  
Daniel Edwards
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Advanced Disease ◽  
Diagnostic Delay ◽  
Psychological Consequences ◽  
Significant Morbidity ◽  
Recent Developments

Head and neck cancer is a rare, but significantly life-changing diagnosis. Mortality is still high in advanced disease and treatment carries significant morbidity (both physical and psychological). Patients who suffer with the disease have often experienced diagnostic delay and uncertainty with harmful physical and psychological consequences. This experience can be frustrating for patients and with delay they may feel that their needs are not being met, and that they are not being taken seriously. This article aims to detail appropriate referral of patients and recent developments in the treatment and management of head and neck cancer.

scholarly journals Oral Complications of Head and Neck Cancer Therapy

2021 ◽  
Vol 12 (1) ◽  
pp. 52-66
Author(s):  
Maria Kouri ◽  
Athina Vadalouca ◽  
Vasilios Kouloulias ◽  
Erofili Papadopoulou ◽  
Emmanouil Vardas ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Dental Disease ◽  
Significant Morbidity ◽  
Mucosal Integrity ◽  
Oral Complications ◽  
Salivary Function ◽  
Current Therapies

Abstract Current therapies for Head and Neck cancer treatment are extremely advanced. Though, they cause oral complications which have deleterious effects on basic life functions, affect oral and overall health, may lead to significant morbidity and treatment discontinuation and have an impact on survivorship and quality of life. As new therapies are introduced, a new spectrum of oral complications is rising, compromising the mucosal integrity and the salivary function, that may not be recognized, reported and treated properly. Oral complications, often permanent and extremely painful, may include mucositis, xerostomia, dysgeusia, infections, trismus and fibrosis, risk of dental disease and necrosis of the jaw, neurosensory disorders and when targeted therapies and immunotherapy are involved, aphthoid and lichenoid lesions can also be reported. Increased awareness is required for the prevention and management of these complications, which can be best provided by a multidisciplinary team.

scholarly journals Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments

PLoS ONE ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. e0229266 ◽  
Author(s):  
Christoph Evers ◽  
Christian Ostheimer ◽  
Frank Sieker ◽  
Dirk Vordermark ◽  
Daniel Medenwald
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Population Based ◽  
Population Based Study ◽  
Recent Developments

Role of chemotherapy in head and neck cancer: Systemic use of single agents and combinations in advanced disease

1980 ◽  
Vol 2 (3) ◽  
pp. 196-205 ◽  
Author(s):  
Franco M. Muggia ◽  
Marcel Rozencweig ◽  
Arthur E. Louie
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Advanced Disease

scholarly journals Diagnostic delay for head and neck cancer in South India: A Mixed-methods Study.

2020 ◽  
Vol 21 (6) ◽  
pp. 1673-1678
Author(s):  
Sivaraman Ganesan ◽  
Sivanesan Sivagnanganesan ◽  
Mahalakshmy Thulasingam ◽  
Gunaseelan Karunanithi ◽  
Kalaiarasi R ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Mixed Methods ◽  
Head And Neck ◽  
Neck Cancer ◽  
South India ◽  
Diagnostic Delay ◽  
Mixed Methods Study

Utilizing Artificial Intelligence for Head and Neck Cancer Outcomes Prediction From Imaging

2020 ◽  
pp. 084653712094213
Author(s):  
Tricia Chinnery ◽  
Andrew Arifin ◽  
Keng Yeow Tay ◽  
Andrew Leung ◽  
Anthony C. Nichols ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Prediction Models ◽  
Oncologic Outcomes ◽  
Prognostic Impact ◽  
Physician Decision Making ◽  
Area Of Interest ◽  
Recent Developments

Artificial intelligence (AI)-based models have become a growing area of interest in predictive medicine and have the potential to aid physician decision-making to improve patient outcomes. Imaging and radiomics play an increasingly important role in these models. This review summarizes recent developments in the field of radiomics for AI in head and neck cancer. Prediction models for oncologic outcomes, treatment toxicity, and pathological findings have all been created. Exploratory studies are promising; however, validation studies that demonstrate consistency, reproducibility, and prognostic impact remain uncommon. Prospective clinical trials with standardized procedures are required for clinical translation.

Sign in / Sign up

Export Citation Format

Share Document